Condition 101 content is not available at this time, but we are continually updating the site. Please check back.
However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.
Jennifer Wambach is a Neonatologist and a Pediatrics expert in St Louis, Missouri. Wambach has been practicing medicine for over 22 years and is rated as an Elite expert by MediFind in the treatment of Infant Respiratory Distress Syndrome. She is also highly rated in 2 other conditions, according to our data. Her top areas of expertise are Infant Respiratory Distress Syndrome, Acalvaria, High Blood Pressure in Infants, and Arthrogryposis Multiplex Congenita. She is licensed to treat patients in Missouri. Wambach is currently accepting new patients.
Daniel Wegner practices in Nijmegen, Netherlands. Wegner is rated as an Elite expert by MediFind in the treatment of Infant Respiratory Distress Syndrome. He is also highly rated in 6 other conditions, according to our data. His top areas of expertise are Infant Respiratory Distress Syndrome, Type A Insulin Resistance Syndrome, Acanthosis Nigricans, Acute Interstitial Pneumonia, and Lung Transplant.
Carlo Dani practices in Firenze, Italy. Dani is rated as an Elite expert by MediFind in the treatment of Infant Respiratory Distress Syndrome. He is also highly rated in 20 other conditions, according to our data. His top areas of expertise are Premature Infant, Infant Respiratory Distress Syndrome, Patent Ductus Arteriosus, and Infantile Pneumothorax.
Summary: Oxygen treatment is common in management of preterm babies requiring intensive care. Delivery of too much or too little oxygen increase the risk of damage to eyes and lungs, and contributes to death and disability. Oxygen control in preterm infants requires frequent adjustments in the amount of oxygen delivered to the baby. This is generally performed manually by a clinician attending the baby, an...
Summary: This study aims to find out whether the use of angiotensin II, which is a drug to raise blood pressure has been approved by European Medical Agency in August 2019, as an add-on medication to increase blood pressure in patients with COVID-19, acute severe lung injury, inflammation and severe shock, compared with standard medication. In addition, the investigators will collect the data of Anakinra, ...